"Diagnostic Test Approval" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The process of gaining approval by a government regulatory agency for DIAGNOSTIC REAGENTS AND TEST KITS. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance.
| Descriptor ID |
D057069
|
| MeSH Number(s) |
E05.337.275.500 N06.850.210.275.500
|
| Concept/Terms |
Diagnostic Test Approval- Diagnostic Test Approval
- Approval, Diagnostic Test
- Approvals, Diagnostic Test
- Diagnostic Test Approvals
|
Below are MeSH descriptors whose meaning is more general than "Diagnostic Test Approval".
Below are MeSH descriptors whose meaning is more specific than "Diagnostic Test Approval".
This graph shows the total number of publications written about "Diagnostic Test Approval" by people in this website by year, and whether "Diagnostic Test Approval" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 0 | 1 |
| 2020 | 2 | 2 | 4 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Diagnostic Test Approval" by people in Profiles.
-
Successful implementation of SARS-CoV-2 testing in midst of pandemic with emphasis on all phases of testing. J Clin Pathol. 2021 May; 74(5):273-278.
-
The FDA's Experience with Covid-19 Antibody Tests. N Engl J Med. 2021 02 18; 384(7):592-594.
-
Testing in a Pandemic - Improving Access, Coordination, and Prioritization. N Engl J Med. 2021 Jan 21; 384(3):197-199.
-
Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses. Curr Med Res Opin. 2021 02; 37(2):207-217.
-
Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2021 03; 19(3):171-183.
-
Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19. J Clin Microbiol. 2020 Jul 23; 58(8).
-
Understanding, Verifying, and Implementing Emergency Use Authorization Molecular Diagnostics for the Detection of SARS-CoV-2 RNA. J Clin Microbiol. 2020 Jul 23; 58(8).
-
Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic? Eur Heart J. 2020 06 14; 41(23):2140-2144.
-
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations. J Exp Clin Cancer Res. 2018 Mar 05; 37(1):47.